Sector: Consumer Non-Cyclicals | Industry: Food Retail & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 250 E Parkcenter Blvd BOISE ID 83706-3940 |
Tel: | N/A |
Website: | https://www.albertsonscompanies.com |
IR: | See website |
Key People | ||
James L. Donald Co-Chairman of the Board | Omer Gajial Executive Vice President - Health, Chief Digital Officer | Chan W. Galbato Co-Chairman of the Board |
Sharon L. Mccollam President, Chief Financial Officer | Vivekanan Sankaran Chief Executive Officer, Director | Brian Kevin Turner Vice Chairman of the Board |
Susan Morris Chief Operations Officer, Executive Vice President | Michael Theilmann Chief Human Resource Officer, Executive Vice President | Anuj Dhanda Executive Vice President, Chief Technology and Transformation Officer | Thomas M. Moriarty Executive Vice President, General Counsel |
Business Overview |
Albertsons Companies, Inc. is a food and drug retailer in the United States. The Company is engaged in the operation of food and drug retail stores that offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company operates approximately 2,271 stores across 34 states and the District of Columbia under 24 banners including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, Market Street, Haggen, Kings Food Markets and Balducci's Food Lovers Market. The Company operates approximately 1,722 pharmacies, 1,328 in-store branded coffee shops, 401 associated fuel centers, 22 dedicated distribution centers, 19 manufacturing facilities and various digital platforms. Its own brands include Signature SELECT, Open Nature, Signature Cafe, Lucerne, Waterfront BISTRO, Primo Taglio, Signature Care, Signature Reserve and Value Corner. |
Financial Overview |
For the 28 weeks ended 09 September 2023, Albertsons Companies Inc revenues increased 3% to $42.34B. Net income applicable to common stockholders decreased 15% to $683.2M. Revenues reflect Pharmacy segment increase of 18% to $1.74B, Retail Sales -Non-Perishables increase of 4% to $21.32B. Net income was offset by Selling and administrative expenses increase of 2% to $9.55B (expense). Dividend per share totaled to $0.24. |
Employees: | 290,000 as of Feb 25, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $20,547M as of Sep 9, 2023 |
Annual revenue (TTM): | $78,761M as of Sep 9, 2023 |
EBITDA (TTM): | $4,142M as of Sep 9, 2023 |
Net annual income (TTM): | $1,091M as of Sep 9, 2023 |
Free cash flow (TTM): | -$3,843M as of Sep 9, 2023 |
Net Debt Last Fiscal Year: | $8,165M as of Sep 9, 2023 |
Shares outstanding: | 575,892,726 as of Oct 13, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |